Who owns Opus Genetics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IRD from SEC Form 13F filings across 102 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 102 institutions disclosed 56.5M shares of Opus Genetics, Inc. worth $232.2M — about 59.2% of shares outstanding; the largest disclosed holder is Caligan Partners LP. Source: SEC Form 13F filings, parsed by EvidInvest.
102
13F holders
$232.2M
value, 2026 filers
59.2%
of shares outstanding (56.5M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IRD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Caligan Partners LP | 6.1M | $25.0M | 1.2% | 6.4% | 0.0% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.0M | $24.8M | 0.0% | 6.3% | 0.0% |
| 3 | BIOS Capital Management, LP | 3.7M | $15.1M | 36.3% | 3.9% | 0.0% |
| 4 | BlackRock, Inc. | 3.1M | $12.8M | 0.0% | 3.3% | +2009.4% |
| 5 | Balyasny Asset Management L.P. | 3.1M | $12.7M | 0.0% | 3.2% | +13.6% |
| 6 | Nantahala Capital Management, LLC | 3.1M | $12.6M | 0.4% | 3.2% | +82.1% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $12.2M | 0.0% | 3.1% | +20.8% |
| 8 | Boxer Capital Management, LLC | 2.8M | $11.6M | 0.9% | 2.9% | +25.1% |
| 9 | Trails Edge Capital Partners, LP | 2.7M | $11.3M | 1.8% | 2.9% | +448.7% |
| 10 | MILLENNIUM MANAGEMENT LLC | 2.3M | $9.5M | 0.0% | 2.4% | -12.5% |
| 11 | GREAT POINT PARTNERS LLC | 2.0M | $8.1M | 1.5% | 2.1% | +507.4% |
| 12 | MARSHALL WACE, LLP | 1.9M | $8.0M | 0.0% | 2% | -15.9% |
| 13 | ADAR1 Capital Management, LLC | 1.8M | $7.3M | 0.3% | 1.9% | -3.5% |
| 14 | GOLDMAN SACHS GROUP INC | 1.5M | $6.3M | 0.0% | 1.6% | +367.3% |
| 15 | Woodline Partners LP | 1.4M | $5.9M | 0.0% | 1.5% | +6.0% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $5.6M | 0.0% | 1.4% | +154.1% |
| 17 | BOOTHBAY FUND MANAGEMENT, LLC | 1.2M | $4.9M | 0.1% | 1.2% | 0.0% |
| 18 | Opaleye Management Inc. | 1.1M | $4.6M | 0.4% | 1.2% | +0.4% |
| 19 | STATE STREET CORP | 790,136 | $3.2M | 0.0% | 0.8% | +295.2% |
| 20 | Bleichroeder LP | 736,842 | $3.0M | 0.5% | 0.8% | 0.0% |
| 21 | UBS Group AG | 683,895 | $2.8M | 0.0% | 0.7% | +165.4% |
| 22 | CITADEL ADVISORS LLC | 665,662 | $2.7M | 0.0% | 0.7% | +450.6% |
| 23 | MORGAN STANLEY | 464,900 | $1.9M | 0.0% | 0.5% | +1076.3% |
| 24 | NORTHERN TRUST CORP | 442,154 | $1.8M | 0.0% | 0.5% | +368.3% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 410,375 | $1.7M | 0.0% | 0.4% | +45.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.